Iron-Dextran (CAS 9004-66-4)
See product citations (2)
QUICK LINKS
Iron-Dextran is a complex of ferric iron and dextran, used extensively in scientific research to study iron metabolism and address issues related to iron deficiency. The mechanism by which Iron-Dextran operates involves the controlled release of iron, mimicking the body′s natural process of iron uptake and utilization. This complex is particularly valuable in research due to its ability to bypass the regulatory mechanisms of iron absorption, providing a direct source of iron that can be utilized for hemoglobin synthesis and replenishment of iron stores in experimental applications. Its role in research extends to investigations into the physiological and molecular mechanisms underlying iron homeostasis, the effects of iron overload, and the development of strategies to manage iron deficiency through dietary supplementation. Iron-Dextran′s utility in these areas stems from its predictable pharmacokinetics allowing for precise modulation of iron levels in research models.
Iron-Dextran (CAS 9004-66-4) References
- Hookworms, malaria and vitamin A deficiency contribute to anemia and iron deficiency among pregnant women in the plains of Nepal. | Dreyfuss, ML., et al. 2000. J Nutr. 130: 2527-36. PMID: 11015485
- Iron deficiency anemia: a call for aggressive diagnostic evaluation. | Brady, PG. 2007. South Med J. 100: 966-7. PMID: 17943034
- Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells. | Roth, S., et al. 2008. Transl Res. 151: 36-44. PMID: 18061126
- Severe anemia in Malawian children. | Calis, JC., et al. 2008. N Engl J Med. 358: 888-99. PMID: 18305266
- Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients. | Ibrahim, HN., et al. 2009. Clin J Am Soc Nephrol. 4: 623-9. PMID: 19211669
- Lipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease. | Ganguli, A., et al. 2009. Ren Fail. 31: 106-10. PMID: 19212906
- Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease. | Sinha, S., et al. 2009. J Ren Care. 35: 67-73. PMID: 19432851
- Evolution of iv iron compounds over the last century. | Macdougall, IC. 2009. J Ren Care. 35 Suppl 2: 8-13. PMID: 19891680
- Physical and chemical stability of iron sucrose in parenteral nutrition. | MacKay, M., et al. 2009. Nutr Clin Pract. 24: 733-7. PMID: 19955552
- Enhancement of irradiation effects on cancer cells by cross-linked dextran-coated iron oxide (CLIO) nanoparticles. | Huang, FK., et al. 2010. Phys Med Biol. 55: 469-82. PMID: 20023329
- Iron replacement therapy: assessing today's options to prepare for bundling. | Yee, J. 2010. Nephrol News Issues. 24: suppl 1-8. PMID: 20333988
- Intravenous iron dextran for severe refractory restless legs syndrome. | Ondo, WG. 2010. Sleep Med. 11: 494-6. PMID: 20371212
- Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia. | Auerbach, M., et al. 2011. Am J Hematol. 86: 860-2. PMID: 21922526
- Comparison effects of dietary iron dextran and bacterial-iron supplementation on growth performance, fecal microbial flora, and blood profiles in sows and their litters. | Zhao, P., et al. 2015. Anim Sci J. 86: 937-42. PMID: 26153734
- Safety and efficacy of iron dextran as a feed additive for piglets. | , ., et al. 2017. EFSA J. 15: e04701. PMID: 32625406
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Iron-Dextran, 25 ml | sc-215191 | 25 ml | $200.00 | |||
Iron-Dextran, 100 ml | sc-215191A | 100 ml | $520.00 |